Theravance Biopharma TBPH Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpensesOther.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's prepaid & other current?
- Theravance Biopharma (TBPH) reported prepaid & other current of -$1.67M in Q1 2026.
- How has Theravance Biopharma's prepaid & other current changed year-over-year?
- Theravance Biopharma's prepaid & other current decreased by 1025.7% year-over-year, from -$148K to -$1.67M.
- What is the long-term trend for Theravance Biopharma's prepaid & other current?
- Over 2 years (2021 to 2025), Theravance Biopharma's prepaid & other current has grown at a 8.3% compound annual growth rate (CAGR), from -$2.87M to $3.36M.
- What does prepaid & other current mean?
- This represents the net change in advance payments for goods or services that will be consumed in future periods. It is a standard working capital metric that reflects the company's short-term liquidity management regarding operational overhead. A significant increase may signal higher future operational costs or changes in procurement strategy.